FindTrial
Sign In

Risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndrome

Risk-reducing salpingo-oohorectomy for hereditary breast and ovarian syndrome - RRSO for HBOC

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025823
Enrollment
10
Registered
2017-01-24
Start date
2014-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary breast and ovarian caccer

Interventions

abdominal or laparoscopic bilateral salpingo-oohorectomy

Sponsors

Nara Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: BRCA1 and BRCA2 mutation carrier

Exclusion criteria

Exclusion criteria: BRCA1 and BRCA2 gene mutation negative case

Design outcomes

Primary

MeasureTime frame
The Preventing treatment of he ovarian cancer high risk case (BRCA1 and BRCA2 mutation carrier)—

Countries

Japan

Contacts

Public ContactKana Iwai

Nara Medical University Gynecology and Obstetrics

iwaikana@naramed-u.ac.jp0744223051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026